NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,555,829 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$536,300 per month
Our analysis indicates Nature.com generates between $357,511 and $983,155 monthly online from display ads.

Keywords {🔍}

cells, apoptosis, trailr, trail, cll, article, cell, figure, google, scholar, cas, apoltrail, hgsetr, depsipeptide, caspase, patients, valproate, ngml, hdaci, trailinduced, trailhisle, death, signaling, surface, trailhis, expression, receptor, agonistic, receptors, data, human, preparations, ligand, clinical, tumor, cancer, nature, lymphocytic, mabs, primary, processing, chronic, shown, sensitization, primarily, activity, leukemia, forms, results, lines,

Topics {✒️}

nature portfolio permissions reprints tnf-related apoptosis-inducing ligand privacy policy epstein–barr virus-negative burkitt' nature 364 nature related apoptosis-inducing ligand tumour-necrosis factor superfamily advertising tumour necrosis factor histone deacetylase inhibitors related b-cell malignancies death-inducing signaling complex b-cell prolymphocytic leukemia chronic lymphocytic leukaemia development chronic lymphocytic leukemia isotype-matched control antibody conjugated mouse anti-dr4 anti-trail receptor antibodies social media regulate agonist-specific mechanisms materials media death receptor-induced apoptosis author correspondence expresses primarily trail-r1 adaptor molecule fadd/mort1 tumor cell lines permissions express surface trail-r2 histone deacetylase trail-r1 decreased markedly potentiating trail-induced-apoptosis potentiated trail-induced apoptosis primary tumor signals cell surface trail-r2 temperature-sensitive differential affinity cytotoxic ligand trail trail-r1-selective variants primary tumor cells apo2l/trail signals primarily recombinant apo2l/trail versions apoptosis-inducing ability sensitize tumor cells agonistic trail-r1 ab anti-fas antibody distinct caspase cascades cell death differ trail-r2 increased markedly

Questions {❓}

• Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
         description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
         datePublished:2005-04-29T00:00:00Z
         dateModified:2005-04-29T00:00:00Z
         pageStart:773
         pageEnd:782
         sameAs:https://doi.org/10.1038/sj.cdd.4401649
         keywords:
            chronic lymphocytic leukaemia
            tumor necrosis factor-apoptosis inducing ligand
            TRAIL-R1
            histone deacetylase inhibitors
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Stem Cells
            Apoptosis
            Cell Cycle Analysis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
         isPartOf:
            name:Cell Death & Differentiation
            issn:
               1476-5403
               1350-9047
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M MacFarlane
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S Inoue
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S L Kohlhaas
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Majid
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Harper
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D B J Kennedy
               affiliation:
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M J S Dyer
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G M Cohen
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
      description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
      datePublished:2005-04-29T00:00:00Z
      dateModified:2005-04-29T00:00:00Z
      pageStart:773
      pageEnd:782
      sameAs:https://doi.org/10.1038/sj.cdd.4401649
      keywords:
         chronic lymphocytic leukaemia
         tumor necrosis factor-apoptosis inducing ligand
         TRAIL-R1
         histone deacetylase inhibitors
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Stem Cells
         Apoptosis
         Cell Cycle Analysis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
      isPartOf:
         name:Cell Death & Differentiation
         issn:
            1476-5403
            1350-9047
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M MacFarlane
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S Inoue
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S L Kohlhaas
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Majid
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Harper
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D B J Kennedy
            affiliation:
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M J S Dyer
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G M Cohen
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Differentiation
      issn:
         1476-5403
         1350-9047
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M MacFarlane
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S Inoue
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S L Kohlhaas
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:A Majid
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:N Harper
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:D B J Kennedy
      affiliation:
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:M J S Dyer
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:G M Cohen
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(123)

• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/BLAST/?
• What's the financial gain of http://www.ebi.ac.uk/clustalw/?
• How much income does https://doi.org/10.1172%2FJCI6926 have?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Safety%20and%20antitumor%20activity%20of%20recombinant%20soluble%20Apo2%20ligand&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI6926&volume=104&pages=155-162&publication_year=1999&author=Ashkenazi%2CA&author=Pai%2CRC&author=Fong%2CS&author=Leung%2CS&author=Lawrence%2CDA&author=Marsters%2CSA&author=Blackie%2CC&author=Chang%2CL&author=McMurtrey%2CAE&author=Hebert%2CA&author=DeForge%2CL&author=Koumenis%2CIL&author=Lewis%2CD&author=Harris%2CL&author=Bussiere%2CJ&author=Koeppen%2CH&author=Shahrokh%2CZ&author=Schwall%2CRH have monthly?
• How much revenue does https://doi.org/10.1016%2F1074-7613%2895%2990057-8 bring in?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-682&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ&author=Din%2CWS&author=Huang%2CCP&author=Nicholl%2CJK&author=Sutherland%2CGR&author=Smith%2CTD&author=Rauch%2CC&author=Smith%2CCA&author=Goodwin%2CRG making per month?
• What's the monthly income of https://doi.org/10.1074%2Fjbc.271.22.12687?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20Apo-2%20ligand%2C%20a%20new%20member%20of%20the%20tumor%20necrosis%20factor%20cytokine%20family&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.271.22.12687&volume=271&pages=12687-12690&publication_year=1996&author=Pitti%2CRM&author=Marsters%2CSA&author=Ruppert%2CS&author=Donahue%2CCJ&author=Moore%2CA&author=Ashkenazi%2CA generate?
• How much does https://doi.org/10.1038%2F5517 make?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat.%20Med.&doi=10.1038%2F5517&volume=5&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM&author=Chin%2CW&author=Jones%2CJ&author=Woodward%2CA&author=Le%2CT&author=Smith%2CC&author=Smolak%2CP&author=Goodwin%2CRG&author=Rauch%2CCT&author=Schuh%2CJC&author=Lynch%2CDH
• How much revenue does https://doi.org/10.1038%2F35008667 produce monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=TRAIL%20receptor-2%20signals%20apoptosis%20through%20FADD%20and%20caspase-8&journal=Nat.%20Cell%20Biol.&doi=10.1038%2F35008667&volume=2&pages=241-243&publication_year=2000&author=Bodmer%2CJL&author=Holler%2CN&author=Reynard%2CS&author=Vinciguerra%2CP&author=Schneider%2CP&author=Juo%2CP&author=Blenis%2CJ&author=Tschopp%2CJ bring in?
• Earnings of https://doi.org/10.1016%2FS1074-7613%2800%2980212-5
• How profitable is http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL-dependent%20recruitment%20of%20endogenous%20FADD%20and%20caspase-8%20to%20death%20receptors%204%20and%205&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980212-5&volume=12&pages=611-620&publication_year=2000&author=Kischkel%2CFC&author=Lawrence%2CDA&author=Chuntharapai%2CA&author=Schow%2CP&author=Kim%2CKJ&author=Ashkenazi%2CA?
• What's the monthly money flow for https://doi.org/10.1016%2FS1074-7613%2800%2980211-3?
• Income figures for http://scholar.google.com/scholar_lookup?&title=FADD%2FMORT1%20and%20caspase-8%20are%20recruited%20to%20TRAIL%20receptors%201%20and%202%20and%20are%20essential%20for%20apoptosis%20mediated%20by%20TRAIL%20receptor%202&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980211-3&volume=12&pages=599-609&publication_year=2000&author=Sprick%2CMR&author=Weigand%2CMA&author=Rieser%2CE&author=Rauch%2CCT&author=Juo%2CP&author=Blenis%2CJ&author=Krammer%2CPH&author=Walczak%2CH
• https://doi.org/10.1006%2Fexcr.2000.4835 income
• What's the income of http://scholar.google.com/scholar_lookup?&title=Protein%20complexes%20activate%20distinct%20caspase%20cascades%20in%20death%20receptor%20and%20stress-induced%20apoptosis&journal=Exp.%20Cell%20Res.&doi=10.1006%2Fexcr.2000.4835&volume=256&pages=27-33&publication_year=2000&author=Bratton%2CSB&author=MacFarlane%2CM&author=Cain%2CK&author=Cohen%2CGM?
• Get to know what's the income of https://doi.org/10.1038%2Fnrc821
• How much profit does http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumour-necrosis%20factor%20superfamily&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc821&volume=2&pages=420-430&publication_year=2002&author=Ashkenazi%2CA make?
• What's the income generated by https://doi.org/10.1126%2Fscience.281.5381.1305 each month?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Death%20receptors%3A%20signaling%20and%20modulation&journal=Science&doi=10.1126%2Fscience.281.5381.1305&volume=281&pages=1305-1308&publication_year=1998&author=Ashkenazi%2CA&author=Dixit%2CVM?
• https://doi.org/10.1038%2Fsj.cdd.4401187's revenue stream
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL%20and%20its%20death%20and%20decoy%20receptors&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401187&volume=10&pages=66-75&publication_year=2003&author=LeBlanc%2CHN&author=Ashkenazi%2CA?
• What's the revenue for https://doi.org/10.1038%2F75045?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Apoptosis%20induced%20in%20normal%20human%20hepatocytes%20by%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand&journal=Nat.%20Med.&doi=10.1038%2F75045&volume=6&pages=564-567&publication_year=2000&author=Jo%2CM&author=Kim%2CTH&author=Seol%2CDW&author=Esplen%2CJE&author=Dorko%2CK&author=Billiar%2CTR&author=Strom%2CSC?
• What's the profit of https://doi.org/10.1046%2Fj.1365-2141.2000.02404.x?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Expression%20of%20tumour%20necrosis%20factor%20%28TNF%29-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20receptors%20and%20sensitivity%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B-cell%20acute%20lymphoblastic%20leukaemia%20cells&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2000.02404.x&volume=111&pages=580-586&publication_year=2000&author=Clodi%2CK&author=Wimmer%2CD&author=Li%2CY&author=Goodwin%2CR&author=Jaeger%2CU&author=Mann%2CG&author=Gadner%2CH&author=Younes%2CA
• How much does https://doi.org/10.1038%2Fsj.onc.1205853 pull in?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B%20cell%20chronic%20lymphocytic%20leukaemia&journal=Oncogene&doi=10.1038%2Fsj.onc.1205853&volume=21&pages=6809-6818&publication_year=2002&author=MacFarlane%2CM&author=Harper%2CN&author=Snowden%2CRT&author=Dyer%2CMJ&author=Barnett%2CGA&author=Pringle%2CJH&author=Cohen%2CGM?
• Monthly income for https://doi.org/10.1046%2Fj.1365-2141.1997.4393250.x
• How much does http://scholar.google.com/scholar_lookup?&title=Activity%20of%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20in%20haematological%20malignancies&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.1997.4393250.x&volume=99&pages=618-624&publication_year=1997&author=Snell%2CV&author=Clodi%2CK&author=Zhao%2CS&author=Goodwin%2CR&author=Thomas%2CEK&author=Morris%2CSW&author=Kadin%2CME&author=Cabanillas%2CF&author=Andreeff%2CM&author=Younes%2CA generate monthly?
• What is the earnings of https://doi.org/10.1016%2Fj.drup.2004.03.002?
• How much does http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20therapeutic%20potential%20of%20TRAIL%20by%20cancer%20chemotherapy%20and%20irradiation%3A%20mechanisms%20and%20clinical%20implications&journal=Drug%20Resist.%20Update&doi=10.1016%2Fj.drup.2004.03.002&volume=7&pages=139-156&publication_year=2004&author=Shankar%2CS&author=Srivastava%2CRK make?
• How much does https://doi.org/10.1038%2Fsj.cdd.4401535 bring in each month?
• How much money does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20inhibitors%20potentiate%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29-induced%20apoptosis%20in%20lymphoid%20malignancies&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401535&volume=11&issue=Suppl%202&pages=S193-206&publication_year=2004&author=Inoue%2CS&author=MacFarlane%2CM&author=Harper%2CN&author=Wheat%2CLM&author=Dyer%2CMJ&author=Cohen%2CGM make?
• How much profit does https://doi.org/10.1038%2F35106079 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20and%20cancer%3A%20causes%20and%20therapies&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2F35106079&volume=1&pages=194-202&publication_year=2001&author=Marks%2CP&author=Rifkind%2CRA&author=Richon%2CVM&author=Breslow%2CR&author=Miller%2CT&author=Kelly%2CWK rake in every month?
• What's the profit of https://doi.org/10.1016%2FS1471-4892%2803%2900084-5?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases&journal=Curr.%20Opin.%20Pharmacol.&doi=10.1016%2FS1471-4892%2803%2900084-5&volume=3&pages=344-351&publication_year=2003&author=Marks%2CPA&author=Miller%2CT&author=Richon%2CVM?
• How much does https://doi.org/10.1074%2Fjbc.M409578200 gross monthly?
• How much income does http://scholar.google.com/scholar_lookup?&title=The%20C-terminal%20tails%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20and%20Fas%20receptors%20have%20opposing%20functions%20in%20Fas-associated%20Death%20Domain%20%28FADD%29%20recruitment%20and%20can%20regulate%20agonist-specific%20mechanisms%20of%20receptor%20activation&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M409578200&volume=279&pages=52479-52486&publication_year=2004&author=Thomas%2CLR&author=Johnson%2CRL&author=Reed%2CJC&author=Thorburn%2CA have?
• How much does https://doi.org/10.1074%2Fjbc.272.41.25417 pull in?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Identification%20and%20molecular%20cloning%20of%20two%20novel%20receptors%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.272.41.25417&volume=272&pages=25417-25420&publication_year=1997&author=MacFarlane%2CM&author=Ahmad%2CM&author=Srinivasula%2CSM&author=Fernandes-Alnemri%2CT&author=Cohen%2CGM&author=Alnemri%2CES generate?
• Find out how much https://doi.org/10.1074%2Fjbc.M101287200 earns monthly
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20is%20a%20direct%20target%20of%20valproic%20acid%2C%20a%20potent%20anticonvulsant%2C%20mood%20stabilizer%2C%20and%20teratogen&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M101287200&volume=276&pages=36734-36741&publication_year=2001&author=Phiel%2CCJ&author=Zhang%2CF&author=Huang%2CEY&author=Guenther%2CMG&author=Lazar%2CMA&author=Klein%2CPS is on a monthly basis
• How much money does https://doi.org/10.1093%2Femboj%2F20.24.6969 generate?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Valproic%20acid%20defines%20a%20novel%20class%20of%20HDAC%20inhibitors%20inducing%20differentiation%20of%20transformed%20cells&journal=EMBO%20J.&doi=10.1093%2Femboj%2F20.24.6969&volume=20&pages=6969-6978&publication_year=2001&author=Gottlicher%2CM&author=Minucci%2CS&author=Zhu%2CP&author=Kramer%2COH&author=Schimpf%2CA&author=Giavara%2CS&author=Sleeman%2CJP&author=Lo%20Coco%2CF&author=Nervi%2CC&author=Pelicci%2CPG&author=Heinzel%2CT
• What's https://doi.org/10.1083%2Fjcb.148.6.1239's gross income?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Active%20caspases%20and%20cleaved%20cytokeratins%20are%20sequestered%20into%20cytoplasmic%20inclusions%20in%20TRAIL-induced%20apoptosis&journal=J.%20Cell%20Biol.&doi=10.1083%2Fjcb.148.6.1239&volume=148&pages=1239-1254&publication_year=2000&author=MacFarlane%2CM&author=Merrison%2CW&author=Dinsdale%2CD&author=Cohen%2CGM?
• Find out how much https://doi.org/10.1126%2Fscience.282.5393.1497 earns monthly
• How much does http://scholar.google.com/scholar_lookup?&title=Requirement%20for%20p53%20and%20p21%20to%20sustain%20G2%20arrest%20after%20DNA%20damage&journal=Science&doi=10.1126%2Fscience.282.5393.1497&volume=282&pages=1497-1501&publication_year=1998&author=Bunz%2CF&author=Dutriaux%2CA&author=Lengauer%2CC&author=Waldman%2CT&author=Zhou%2CS&author=Brown%2CJP&author=Sedivy%2CJM&author=Kinzler%2CKW&author=Vogelstein%2CB pull in?
• Get to know https://doi.org/10.1056%2FNEJM200012283432602's earnings
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Genomic%20aberrations%20and%20survival%20in%20chronic%20lymphocytic%20leukemia&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJM200012283432602&volume=343&pages=1910-1916&publication_year=2000&author=Dohner%2CH&author=Stilgenbauer%2CS&author=Benner%2CA&author=Leupolt%2CE&author=Krober%2CA&author=Bullinger%2CL&author=Dohner%2CK&author=Bentz%2CM&author=Lichter%2CP?
• See how much https://doi.org/10.1002%2Fcncr.0680 makes per month
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Frequency%20and%20type%20of%20serious%20infections%20in%20fludarabine-refractory%20B-cell%20chronic%20lymphocytic%20leukemia%20and%20small%20lymphocytic%20lymphoma%3A%20implications%20for%20clinical%20trials%20in%20this%20patient%20population&journal=Cancer&doi=10.1002%2Fcncr.0680&volume=94&pages=2033-2039&publication_year=2002&author=Perkins%2CJG&author=Flynn%2CJM&author=Howard%2CRS&author=Byrd%2CJC?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477713
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Unmutated%20Ig%20V%28H%29%20genes%20are%20associated%20with%20a%20more%20aggressive%20form%20of%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1848-1854&publication_year=1999&author=Hamblin%2CTJ&author=Davis%2CZ&author=Gardiner%2CA&author=Oscier%2CDG&author=Stevenson%2CFK?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477712?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Ig%20V%20gene%20mutation%20status%20and%20CD38%20expression%20as%20novel%20prognostic%20indicators%20in%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1840-1847&publication_year=1999&author=Damle%2CRN&author=Wasil%2CT&author=Fais%2CF&author=Ghiotto%2CF&author=Valetto%2CA&author=Allen%2CSL&author=Buchbinder%2CA&author=Budman%2CD&author=Dittmar%2CK&author=Kolitz%2CJ&author=Lichtman%2CSM&author=Schulman%2CP&author=Vinciguerra%2CVP&author=Rai%2CKR&author=Ferrarini%2CM&author=Chiorazzi%2CN
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Molecular%20determinants%20of%20response%20to%20TRAIL%20in%20killing%20of%20normal%20and%20cancer%20cells&journal=Clin.%20Cancer%20Res.&volume=6&pages=335-346&publication_year=2000&author=Kim%2CK&author=Fisher%2CMJ&author=Xu%2CSQ&author=el-Deiry%2CWS?
• See how much https://doi.org/10.1046%2Fj.1365-2141.2003.04699.x makes per month
• How much profit is http://scholar.google.com/scholar_lookup?&title=Chemical%20sensitization%20and%20regulation%20of%20TRAIL-induced%20apoptosis%20in%20a%20panel%20of%20B-lymphocytic%20leukaemia%20cell%20lines&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2003.04699.x&volume=123&pages=921-932&publication_year=2003&author=Kang%2CJ&author=Kisenge%2CRR&author=Toyoda%2CH&author=Tanaka%2CS&author=Bu%2CJ&author=Azuma%2CE&author=KomadaY%2C making per month?
• Financial intake of https://doi.org/10.1074%2Fjbc.M910438199
• See how much http://scholar.google.com/scholar_lookup?&title=Temperature-sensitive%20differential%20affinity%20of%20TRAIL%20for%20its%20receptors.%20DR5%20is%20the%20highest%20affinity%20receptor&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M910438199&volume=275&pages=23319-23325&publication_year=2000&author=Truneh%2CA&author=Sharma%2CS&author=Silverman%2CC&author=Khandekar%2CS&author=Reddy%2CMP&author=Deen%2CKC&author=McLaughlin%2CMM&author=Srinivasula%2CSM&author=Livi%2CGP&author=Marshall%2CLA&author=Alnemri%2CES&author=Williams%2CWV&author=Doyle%2CML makes per month
• How much revenue does https://doi.org/10.1182%2Fblood-2003-12-4333 produce monthly?
• How much income does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20myelodysplastic%20syndromes%20with%20valproic%20acid%20alone%20or%20in%20combination%20with%20all-trans%20retinoic%20acid&journal=Blood&doi=10.1182%2Fblood-2003-12-4333&volume=104&pages=1266-1269&publication_year=2004&author=Kuendgen%2CA&author=Strupp%2CC&author=Aivado%2CM&author=Bernhardt%2CA&author=Hildebrandt%2CB&author=Haas%2CR&author=Germing%2CU&author=Gattermann%2CN have?
• https://doi.org/10.1097%2F00062752-200207000-00010's revenue stream
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20as%20therapeutic%20targets%20in%20hematologic%20malignancies&journal=Curr.%20Opin.%20Hematol.&doi=10.1097%2F00062752-200207000-00010&volume=9&pages=322-332&publication_year=2002&author=Melnick%2CA&author=Licht%2CJD?
• Get to know https://doi.org/10.1074%2Fjbc.M410660200's earnings
• Revenue of http://scholar.google.com/scholar_lookup?&title=Receptor-selective%20mutants%20of%20apoptosis-inducing%20ligand%202L%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20reveal%20a%20greater%20contribution%20of%20death%20receptor%20%28DR%29%205%20than%20DR4%20to%20apoptosis%20signaling&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M410660200&volume=280&pages=2205-2212&publication_year=2005&author=Kelley%2CRF&author=Totpal%2CK&author=Lindstrom%2CSH&author=Mathieu%2CM&author=Billeci%2CK&author=Deforge%2CL&author=Pai%2CR&author=Hymowitz%2CSG&author=Ashkenazi%2CA
• https://doi.org/10.1038%2F91000's financial summary
• http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20a%20novel%20anti-human%20DR5%20monoclonal%20antibody%20without%20hepatocyte%20cytotoxicity&journal=Nat.%20Med.&doi=10.1038%2F91000&volume=7&pages=954-960&publication_year=2001&author=Ichikawa%2CK&author=Liu%2CW&author=Zhao%2CL&author=Wang%2CZ&author=Liu%2CD&author=Ohtsuka%2CT&author=Zhang%2CH&author=Mountz%2CJD&author=Koopman%2CWJ&author=Kimberly%2CRP&author=Zhou%2CT's total income per month
• Monthly income for https://doi.org/10.1182%2Fblood.V98.3.795
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=TRAIL%2FApo2L%20ligand%20selectively%20induces%20apoptosis%20and%20overcomes%20drug%20resistance%20in%20multiple%20myeloma%3A%20therapeutic%20applications&journal=Blood&doi=10.1182%2Fblood.V98.3.795&volume=98&pages=795-804&publication_year=2001&author=Mitsiades%2CCS&author=Treon%2CSP&author=Mitsiades%2CN&author=Shima%2CY&author=Richardson%2CP&author=Schlossman%2CR&author=Hideshima%2CT&author=Anderson%2CKC?
• How much profit is https://doi.org/10.1038%2F364806a0 making per month?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Lethal%20effect%20of%20the%20anti-Fas%20antibody%20in%20mice&journal=Nature&doi=10.1038%2F364806a0&volume=364&pages=806-809&publication_year=1993&author=Ogasawara%2CJ&author=Watanabe-Fukunaga%2CR&author=Adachi%2CM&author=Matsuzawa%2CA&author=Kasugai%2CT&author=Kitamura%2CY&author=Itoh%2CN&author=Suda%2CT&author=Nagata%2CS bring in?
• How much does https://doi.org/10.1038%2F86397 earn?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Differential%20hepatocyte%20toxicity%20of%20recombinant%20Apo2L%2FTRAIL%20versions&journal=Nat.%20Med.&doi=10.1038%2F86397&volume=7&pages=383-385&publication_year=2001&author=Lawrence%2CD&author=Shahrokh%2CZ&author=Marsters%2CS&author=Achilles%2CK&author=Shih%2CD&author=Mounho%2CB&author=Hillan%2CK&author=Totpal%2CK&author=DeForge%2CL&author=Schow%2CP&author=Hooley%2CJ&author=Sherwood%2CS&author=Pai%2CR&author=Leung%2CS&author=Khan%2CL&author=Gliniak%2CB&author=Bussiere%2CJ&author=Smith%2CCA&author=Strom%2CSS&author=Kelley%2CS&author=Fox%2CJA&author=Thomas%2CD&author=Ashkenazi%2CA?
• Earnings of https://doi.org/10.1074%2Fjbc.M404541200
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Death%20induction%20by%20recombinant%20native%20TRAIL%20and%20its%20prevention%20by%20a%20caspase%209%20inhibitor%20in%20primary%20human%20esophageal%20epithelial%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M404541200&volume=279&pages=40044-40052&publication_year=2004&author=Kim%2CSH&author=Kim%2CK&author=Kwagh%2CJG&author=Dicker%2CDT&author=Herlyn%2CM&author=Rustgi%2CAK&author=Chen%2CY&author=El-Deiry%2CWS?
• What's the income generated by https://doi.org/10.1038%2Fsj.cdd.4401331 each month?
• Get to know http://scholar.google.com/scholar_lookup?&title=Human%20normal%20hepatocytes%20are%20susceptible%20to%20apoptosis%20signal%20mediated%20by%20both%20TRAIL-R1%20and%20TRAIL-R2&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401331&volume=11&pages=203-207&publication_year=2004&author=Mori%2CE&author=Thomas%2CM&author=Motoki%2CK&author=Nakazawa%2CK&author=Tahara%2CT&author=Tomizuka%2CK&author=Ishida%2CI&author=Kataoka%2CS's earnings
• What's the financial outcome of https://doi.org/10.1158%2F0008-5472.CAN-04-2599?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=TRAIL%20inhibits%20tumor%20growth%20but%20is%20nontoxic%20to%20human%20hepatocytes%20in%20chimeric%20mice&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2599&volume=64&pages=8502-8506&publication_year=2004&author=Hao%2CC&author=Song%2CJH&author=Hsi%2CB&author=Lewis%2CJ&author=Song%2CDK&author=Petruk%2CKC&author=Tyrrell%2CDL&author=Kneteman%2CNM?
• How much does https://doi.org/10.1074%2Fjbc.M109893200 make?
• See how much http://scholar.google.com/scholar_lookup?&title=Bcl-2%20and%20Bcl-xL%20inhibit%20CD95-mediated%20apoptosis%20by%20preventing%20mitochondrial%20release%20of%20Smac%2FDIABLO%20and%20subsequent%20inactivation%20of%20X-linked%20inhibitor-of-apoptosis%20protein&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M109893200&volume=277&pages=11345-11351&publication_year=2002&author=Sun%2CXM&author=Bratton%2CSB&author=Butterworth%2CM&author=MacFarlane%2CM&author=Cohen%2CGM makes per month
• How much does https://doi.org/10.1074%2Fjbc.274.8.5053 generate monthly?
• See how much http://scholar.google.com/scholar_lookup?&title=Distinct%20caspase%20cascades%20are%20initiated%20in%20receptor-mediated%20and%20chemical-induced%20apoptosis&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.274.8.5053&volume=274&pages=5053-5060&publication_year=1999&author=Sun%2CXM&author=MacFarlane%2CM&author=Zhuang%2CJ&author=Wolf%2CBB&author=Green%2CDR&author=Cohen%2CGM makes per month
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9058723's earnings
• How much does http://scholar.google.com/scholar_lookup?&title=p53%20abnormalities%20in%20B-cell%20prolymphocytic%20leukemia&journal=Blood&volume=89&pages=2015-2023&publication_year=1997&author=Lens%2CD&author=De%20Schouwer%2CPJ&author=Hamoudi%2CRA&author=Abdul-Rauf%2CM&author=Farahat%2CN&author=Matutes%2CE&author=Crook%2CT&author=Dyer%2CMJ&author=Catovsky%2CD bring in each month?
• https://doi.org/10.1038%2Fsj.thj.6200325's total income per month
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Characterisation%20of%20TP53%20abnormalities%20in%20chronic%20lymphocytic%20leukaemia&journal=Hematol.%20J.&doi=10.1038%2Fsj.thj.6200325&volume=5&pages=47-54&publication_year=2004&author=Thornton%2CPD&author=Gruszka-Westwood%2CAM&author=Hamoudi%2CRA&author=Atkinson%2CS&author=Kaczmarek%2CP&author=Morilla%2CRM&author=Hilditch%2CBL&author=A%27Hern%2CR&author=Matutes%2CE&author=Catovsky%2CD produce monthly?
• What is the monthly revenue of https://doi.org/10.1038%2Fsj.leu.2403202?
• http://scholar.google.com/scholar_lookup?&title=Design%20and%20standardization%20of%20PCR%20primers%20and%20protocols%20for%20detection%20of%20clonal%20immunoglobulin%20and%20T-cell%20receptor%20gene%20recombinations%20in%20suspect%20lymphoproliferations%3A%20report%20of%20the%20BIOMED-2%20Concerted%20Action%20BMH4-CT98-3936&journal=Leukemia&doi=10.1038%2Fsj.leu.2403202&volume=17&pages=2257-2317&publication_year=2003&author=van%20Dongen%2CJJ&author=Langerak%2CAW&author=Bruggemann%2CM&author=Evans%2CPA&author=Hummel%2CM&author=Lavender%2CFL&author=Delabesse%2CE&author=Davi%2CF&author=Schuuring%2CE&author=Garcia-Sanz%2CR&author=van%20Krieken%2CJH&author=Droese%2CJ&author=Gonzalez%2CD&author=Bastard%2CC&author=White%2CHE&author=Spaargaren%2CM&author=Gonzalez%2CM&author=Parreira%2CA&author=Smith%2CJL&author=Morgan%2CGJ&author=Kneba%2CM&author=Macintyre%2CEA income
• How much does https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=references bring in each month?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20MacFarlane
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20MacFarlane%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Inoue generate monthly?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Inoue%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20L%20Kohlhaas?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20L%20Kohlhaas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Majid net monthly?
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Majid%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N%20Harper produce monthly?
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N%20Harper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20B%20J%20Kennedy
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20B%20J%20Kennedy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20J%20S%20Dyer each month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20J%20S%20Dyer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20M%20Cohen rake in every month?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20M%20Cohen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• How much does https://s100.copyright.com/AppDispatchServlet?title=Chronic%20lymphocytic%20leukemic%20cells%20exhibit%20apoptotic%20signaling%20via%20TRAIL-R1&author=M%20MacFarlane%20et%20al&contentID=10.1038%2Fsj.cdd.4401649©right=Springer%20Nature%20Limited&publication=1350-9047&publicationDate=2005-04-29&publisherName=SpringerNature&orderBeanReset=true generate monthly?
• What's the monthly money flow for https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=citation?
• What's the income generated by https://doi.org/10.1007/s12032-023-02276-3 each month?
• How much revenue does https://doi.org/10.1038/s41375-023-02035-3 bring in?
• Discover the revenue of https://doi.org/10.1038/s41418-022-01059-z
• Learn how profitable https://doi.org/10.1038/cddis.2017.423 is on a monthly basis
• What's the monthly money flow for https://doi.org/10.1038/cdd.2015.174?
• How much profit does https://www.protocols.io/ make?
• See how much https://www.natureindex.com/ makes per month
• Financial intake of http://www.naturechina.com
• How much income is https://www.natureasia.com/ja-jp earning monthly?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref